Circulating Myeloid Cell-derived Extracellular Vesicles as Mediators of Indirect Acute Lung Injury
Blood-borne myeloid cells, neutrophils and monocytes, play a central role in the development of indirect acute lung injury (ALI) during sepsis and noninfectious systemic inflammatory response syndrome. By contrast, the contribution of circulating myeloid cell-derived extracellular vesicles (EVs) to ALI is unknown, despite acute increases in their numbers during sepsis and systemic inflammatory response syndrome. Here, we investigated the direct role of circulating myeloid-EVs in ALI using a mouse isolated perfused lung system and a human cell coculture model of pulmonary vascular inflammation consisting of lung microvascular endothelial cells and peripheral blood mononuclear cells. Total and immunoaffinity-isolated myeloid (CD11b+) and platelet (CD41+) EVs were prepared from the plasma of intravenous LPS-injected endotoxemic donor mice and transferred directly into recipient lungs. Two-hour perfusion of lungs with unfractionated EVs from a single donor induced pulmonary edema formation and increased perfusate concentrations of RAGE (receptor for advanced glycation end products), consistent with lung injury. These responses were abolished in the lungs of monocyte-depleted mice. The isolated myeloid- but not platelet-EVs produced a similar injury response and the acute intravascular release of proinflammatory cytokines and endothelial injury markers. In the in vitro human coculture model, human myeloid- (CD11b+) but not platelet- (CD61+) EVs isolated from LPS-stimulated whole blood induced acute proinflammatory cytokine production and endothelial activation. These findings implicate circulating myeloid-EVs as acute mediators of pulmonary vascular inflammation and edema, suggesting an alternative therapeutic target for attenuation of indirect ALI.
| Errataetall: |
CommentIn: Am J Respir Cell Mol Biol. 2023 Feb;68(2):121-123. - PMID 36214807 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:68 |
|---|---|
| Enthalten in: |
American journal of respiratory cell and molecular biology - 68(2023), 2 vom: 21. Feb., Seite 140-149 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tan, Ying Ying [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Acute lung injury |
|---|
| Anmerkungen: |
Date Completed 02.02.2023 Date Revised 15.02.2023 published: Print CommentIn: Am J Respir Cell Mol Biol. 2023 Feb;68(2):121-123. - PMID 36214807 Citation Status MEDLINE |
|---|
| doi: |
10.1165/rcmb.2022-0207OC |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM346665043 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM346665043 | ||
| 003 | DE-627 | ||
| 005 | 20231226032008.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1165/rcmb.2022-0207OC |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1155.xml |
| 035 | |a (DE-627)NLM346665043 | ||
| 035 | |a (NLM)36150169 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tan, Ying Ying |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Circulating Myeloid Cell-derived Extracellular Vesicles as Mediators of Indirect Acute Lung Injury |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 02.02.2023 | ||
| 500 | |a Date Revised 15.02.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentIn: Am J Respir Cell Mol Biol. 2023 Feb;68(2):121-123. - PMID 36214807 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Blood-borne myeloid cells, neutrophils and monocytes, play a central role in the development of indirect acute lung injury (ALI) during sepsis and noninfectious systemic inflammatory response syndrome. By contrast, the contribution of circulating myeloid cell-derived extracellular vesicles (EVs) to ALI is unknown, despite acute increases in their numbers during sepsis and systemic inflammatory response syndrome. Here, we investigated the direct role of circulating myeloid-EVs in ALI using a mouse isolated perfused lung system and a human cell coculture model of pulmonary vascular inflammation consisting of lung microvascular endothelial cells and peripheral blood mononuclear cells. Total and immunoaffinity-isolated myeloid (CD11b+) and platelet (CD41+) EVs were prepared from the plasma of intravenous LPS-injected endotoxemic donor mice and transferred directly into recipient lungs. Two-hour perfusion of lungs with unfractionated EVs from a single donor induced pulmonary edema formation and increased perfusate concentrations of RAGE (receptor for advanced glycation end products), consistent with lung injury. These responses were abolished in the lungs of monocyte-depleted mice. The isolated myeloid- but not platelet-EVs produced a similar injury response and the acute intravascular release of proinflammatory cytokines and endothelial injury markers. In the in vitro human coculture model, human myeloid- (CD11b+) but not platelet- (CD61+) EVs isolated from LPS-stimulated whole blood induced acute proinflammatory cytokine production and endothelial activation. These findings implicate circulating myeloid-EVs as acute mediators of pulmonary vascular inflammation and edema, suggesting an alternative therapeutic target for attenuation of indirect ALI | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a acute lung injury | |
| 650 | 4 | |a extracellular vesicle | |
| 650 | 4 | |a monocyte | |
| 650 | 4 | |a neutrophil | |
| 650 | 4 | |a sepsis | |
| 650 | 7 | |a Lipopolysaccharides |2 NLM | |
| 700 | 1 | |a O'Dea, Kieran P |e verfasserin |4 aut | |
| 700 | 1 | |a Tsiridou, Diianeira Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Pac Soo, Aurelie |e verfasserin |4 aut | |
| 700 | 1 | |a Koh, Marissa W |e verfasserin |4 aut | |
| 700 | 1 | |a Beckett, Florence |e verfasserin |4 aut | |
| 700 | 1 | |a Takata, Masao |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of respiratory cell and molecular biology |d 1989 |g 68(2023), 2 vom: 21. Feb., Seite 140-149 |w (DE-627)NLM012606170 |x 1535-4989 |7 nnns |
| 773 | 1 | 8 | |g volume:68 |g year:2023 |g number:2 |g day:21 |g month:02 |g pages:140-149 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1165/rcmb.2022-0207OC |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 68 |j 2023 |e 2 |b 21 |c 02 |h 140-149 | ||